Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2001) | Total Docs. (3years) | Total Refs. (2001) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2001) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51 | Journal of Cardiovascular Pharmacology | journal | 0.797 Q1 | 109 | 207 | 1180 | 6444 | 2241 | 1173 | 1.75 | 31.13 |  |
| 52 | Anti-Cancer Drug Design | journal | 0.795 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 53 | Journal of Antibiotics | journal | 0.782 Q1 | 92 | 150 | 542 | 2187 | 647 | 464 | 1.18 | 14.58 |  |
| 54 | Pharmacology Biochemistry and Behavior | journal | 0.761 Q1 | 148 | 243 | 936 | 10486 | 1721 | 931 | 1.74 | 43.15 | |
| 55 | Chemical Biology and Drug Design | journal | 0.736 | 91 | 115 | 356 | 3881 | 561 | 347 | 1.53 | 33.75 | |
| 56 | PharmacoEconomics | journal | 0.732 Q1 | 118 | 108 | 400 | 4797 | 854 | 377 | 2.14 | 44.42 | |
| 57 | Drug Resistance Updates | journal | 0.727 Q1 | 132 | 42 | 155 | 3286 | 324 | 146 | 1.77 | 78.24 | |
| 58 | Antiviral Research | journal | 0.725 Q1 | 151 | 68 | 195 | 2952 | 498 | 195 | 2.12 | 43.41 |  |
| 59 | Clinical Neuropharmacology | journal | 0.721 Q1 | 85 | 64 | 188 | 1886 | 393 | 181 | 1.71 | 29.47 | |
| 60 | European Journal of Clinical Pharmacology | journal | 0.720 Q1 | 123 | 181 | 467 | 3629 | 955 | 432 | 2.03 | 20.05 |  |
| 61 | Journal of Clinical Pharmacology | journal | 0.718 Q1 | 130 | 171 | 491 | 4733 | 1037 | 476 | 2.26 | 27.68 | |
| 62 | Cancer Chemotherapy and Pharmacology | journal | 0.713 Q1 | 122 | 174 | 448 | 4984 | 1008 | 444 | 2.23 | 28.64 | |
| 63 | Journal of Basic and Clinical Physiology and Pharmacology | journal | 0.694 Q1 | 43 | 24 | 82 | 715 | 87 | 80 | 0.29 | 29.79 | |
| 64 | Journal of AOAC International | journal | 0.684 Q1 | 100 | 263 | 518 | 4980 | 675 | 517 | 1.33 | 18.94 | |
| 65 | Journal of Food Biochemistry | journal | 0.681 Q1 | 64 | 36 | 102 | 1014 | 84 | 102 | 0.60 | 28.17 | |
| 66 | Therapeutic Drug Monitoring | journal | 0.670 Q1 | 102 | 109 | 361 | 2918 | 775 | 349 | 2.13 | 26.77 | |
| 67 | Immunopharmacology | journal | 0.666 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 68 | Clinical and Experimental Pharmacology and Physiology | journal | 0.656 Q1 | 115 | 204 | 593 | 6730 | 1010 | 591 | 1.60 | 32.99 | |
| 69 | Inflammation Research | journal | 0.641 Q1 | 107 | 153 | 447 | 4017 | 714 | 435 | 1.37 | 26.25 |  |
| 70 | European Neuropsychopharmacology | journal | 0.640 Q2 | 130 | 72 | 236 | 2827 | 446 | 215 | 1.86 | 39.26 | |
| 71 | Drug Discovery Today | journal | 0.638 Q2 | 215 | 362 | 633 | 5948 | 1063 | 577 | 1.71 | 16.43 | |
| 72 | Canadian Journal of Physiology and Pharmacology | journal | 0.633 Q2 | 95 | 138 | 403 | 5452 | 636 | 401 | 1.29 | 39.51 |  |
| 73 | Journal of Ethnopharmacology | journal | 0.622 Q2 | 231 | 195 | 591 | 4750 | 656 | 590 | 1.01 | 24.36 |  |
| 74 | Pharmacogenomics | journal | 0.616 Q2 | 100 | 40 | 35 | 2061 | 66 | 35 | 1.89 | 51.53 | |
| 75 | Prostaglandins and Other Lipid Mediators | journal | 0.616 Q2 | 86 | 54 | 176 | 2140 | 269 | 172 | 1.75 | 39.63 | |
| 76 | Heterocycles | journal | 0.611 Q2 | 70 | 334 | 1238 | 7775 | 1313 | 1229 | 1.10 | 23.28 |  |
| 77 | Steroids | journal | 0.608 Q2 | 114 | 105 | 322 | 3605 | 717 | 322 | 2.32 | 34.33 | |
| 78 | Biomedical Chromatography | journal | 0.571 Q2 | 71 | 79 | 310 | 2031 | 318 | 309 | 1.00 | 25.71 | |
| 79 | Journal of Peptide Science | journal | 0.571 Q2 | 73 | 66 | 166 | 2222 | 233 | 162 | 1.48 | 33.67 | |
| 80 | Current Opinion in Drug Discovery and Development | journal | 0.561 Q2 | 85 | 82 | 160 | 3724 | 306 | 152 | 1.83 | 45.41 | |
| 81 | Xenobiotica | journal | 0.557 Q2 | 89 | 63 | 275 | 2378 | 561 | 274 | 1.95 | 37.75 | |
| 82 | Journal of Ocular Pharmacology and Therapeutics | journal | 0.553 Q2 | 72 | 59 | 175 | 1568 | 218 | 174 | 1.34 | 26.58 | |
| 83 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | journal | 0.552 Q2 | 150 | 102 | 291 | 5448 | 384 | 291 | 1.22 | 53.41 | |
| 84 | Medical Letter on Drugs and Therapeutics | journal | 0.550 Q2 | 22 | 62 | 167 | 0 | 171 | 167 | 1.23 | 0.00 | |
| 85 | Cytokines, Cellular and Molecular Therapy | journal | 0.549 Q2 | 28 | 0 | 84 | 0 | 127 | 84 | 1.16 | 0.00 | |
| 86 | Antiviral Chemistry and Chemotherapy | journal | 0.547 Q2 | 59 | 37 | 121 | 1504 | 220 | 121 | 1.91 | 40.65 | |
| 87 | Journal of Asian Natural Products Research | journal | 0.542 Q2 | 51 | 47 | 83 | 416 | 53 | 83 | 0.60 | 8.85 | |
| 88 | Reading Teacher | journal | 0.540 Q2 | 60 | 53 | 188 | 1074 | 68 | 188 | 0.32 | 20.26 | |
| 89 | Environmental Toxicology and Pharmacology | journal | 0.526 Q2 | 106 | 42 | 131 | 1727 | 146 | 130 | 1.21 | 41.12 | |
| 90 | Expert Opinion on Investigational Drugs | journal | 0.521 Q2 | 117 | 357 | 580 | 22450 | 915 | 575 | 1.72 | 62.89 | |
| 91 | Japanese Journal of Pharmacology | journal | 0.520 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 92 | Anti-Cancer Drugs | journal | 0.514 Q2 | 102 | 131 | 370 | 4095 | 644 | 369 | 1.65 | 31.26 | |
| 93 | Perspectives in Drug Discovery and Design | journal | 0.508 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 94 | Biomedicine and Pharmacotherapy | journal | 0.504 Q2 | 149 | 100 | 307 | 3078 | 344 | 276 | 1.02 | 30.78 |  |
| 95 | Pharmacology | journal | 0.500 Q2 | 67 | 72 | 219 | 2097 | 305 | 211 | 1.57 | 29.13 | |
| 96 | Journal of Biomolecular Screening | journal | 0.497 Q2 | 86 | 42 | 128 | 885 | 231 | 112 | 2.13 | 21.07 | |
| 97 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.492 Q2 | 68 | 58 | 170 | 1918 | 256 | 152 | 1.53 | 33.07 | |
| 98 | Chemotherapy | journal | 0.492 Q2 | 61 | 98 | 223 | 2623 | 283 | 217 | 1.32 | 26.77 | |
| 99 | International Journal of Neuropsychopharmacology | journal | 0.490 Q2 | 125 | 50 | 113 | 2485 | 150 | 110 | 1.34 | 49.70 | |
| 100 | Journal of Physiology and Pharmacology | journal | 0.484 Q2 | 89 | 67 | 205 | 2471 | 360 | 204 | 1.77 | 36.88 |  |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data